FTC Seeks More Details On Teva's $6.8B Cephalon Buy
The U.S. Federal Trade Commission has asked for more information on Teva Pharmaceutical Industries Ltd.'s plan to buy Cephalon Inc. for $6.8 billion, the companies said Monday....To view the full article, register now.
Already a subscriber? Click here to view full article